The Vox Markets Podcast

In this engaging discussion, Jason Drummond, CEO of MedPal AI, shares insights on the company's groundbreaking NHS Distance Selling Pharmacy contract. He reveals how MedPal dispensed nearly 15,000 prescriptions in just 10 days. Discover the innovative AI-driven app and robotic dispensing technology designed to reshape pharmacy services. Jason also dives into plans for scaling operations and discusses the integration of weight-loss offerings as a customer draw, aiming to become the Amazon of medicine.

Asiamet's executive chairman Tony Manini and chief executive Darryn McClelland join Vox following news of the US$105 million sale of the company's KSK copper project in Indonesia. We discuss the process that led up to the transaction, the way the valuation was determined, the pros and cons of an outright sale versus a joint venture, and what happens next. Asiamet retains the much larger Beutong project, for which it will seek a partner to help move it along. But the plan for proceeds from the KSK sale is to return the bulk of it to shareholders

In this week’s smallcap investing show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 22 stock ideas.00:00 Recent buys/sells. Spectra Systems, Shield Therapeutics and Beeks Financial02:45 Treatt08:05 Brave Bison / M&C Saatchi11:55 TT Electronics16:25 Audioboom20:45 Unite Group / Empiric Student Property26:05 Next 1529:10 Water Intelligence36:45 Zotefoams43:10 Focusrite46:55 Trainline50:50 Anpario53:55 Smiths News57:45 Why are so many smallcaps drifting down on no news?59:35 Spire Healthcare62:00 One Health Group64:45 TP ICAP68:00 Ceres Power72:35 Kromek#SPSY #STX #BKS #TET #BBSN #SAA #TTG #BOOM #UTG #ESP #NFG #WATR #ZTF #TUNE #TRN #SNWS #ANP #SPI #OHGR #TCAP #KMK #CWR

In this interview, Exec Chairman Patrick Desouza of Water Intelligence and CEO Will Knell of American Leak Detection take me through today’s strong Q3’YTD results, positive outlook and increasing momentum. 00:00 Key growth drivers, profit margin expansion and ongoing momentum. 07:30 Progress wrt rolling out both the Dallas template, new products/services and customer feedback. 16:10 Outlook & closing remarks.

Watch on YouTube Focusrite #TUNE has delivered 6.6% revenue growth and a near doubling of operating profit in its 12-month interim results, driven by strong performance in Content Creation and robust gross margins. CEO Tim Carroll and CFO Sally McKone discuss product momentum from Scarlett and Sequential, stabilising trends in Audio Reproduction, and how investment in innovation and supply chain flexibility is positioning the group for long-term growth.

Harena Rare Earths released full year results the other day, showcasing the company's robust financial and operational position in its first major set of financials since listing earlier in the year. The company continues to boost its profile in the US, ahead of major updates on the ground due from its Ampasindava rare earths project in Madagascar. Executive chairman Ivan Murphy joins Vox to give us an update on all the latest developments

Watch on YouTube In this week’s live Exchange, accomplished UK fund manager Dominic Weller of Octopus Investments takes me through his latest thoughts on the following: 00:00 Equity outlook. 02:50 BOKU 07:20 WISE 10:00 PCI-Pal 15:15 GB Group 20:25 Raspberry Pi 24:35 Ensilica 28:00 Volution 30:30 Optima Health 32:05 IXICO 35:05 Diaceutics 37:45 Hvivo 41:30 Ceres Power 46:05 Trainline 49:45 Itaconix 52:25 M&C Saatchi 53:35 Renew Holdings 56:30 Favourite stock idea for next 12 months. Bloomsbury 

Watch on YouTubeCindrigo has listed on the main board of the London Stock Exchange with an initial market capitalisation of £40 million. The company plans to develop geothermal projects in Germany, backed by cashflow from a near-term development project in Finland. Chief executive Lars Gulstrand joins Vox to offer an insight into the precise nature of the opportunity here, especially given that power generation in Germany has undergone such radical transformation in recent years with the mothballing of coal and nuclear.

Watch on YouTube Hemogenyx #HEMO has been given clearance to proceed with the next stage of testing in regard to its HG-CT1 therapy, which is designed to treat leukemia. Hemogenyx's chief executive Vladislav Sandler joins us to talk about the implications of continuing the trials, how they will be structured, and widened with the addition of testing for a group of 12-18 year olds.

Watch on YouTubeGunsynd's Hamish Harris joins Vox for an update, following the release of high grade gold and silver sampling results from the company's Canadian projects. The Barb project showed high gold grades, while Bear Twit showed high silver, lead, and zinc. Harris also updated on a company Gunsynd has a significant stake in, Richmond Hill. There, the opportunity in copper looks highly significant too.